Identification of Biomarkers of Mastitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-01

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Breastfeeding is the optimal feeding for infants. WHO currently promotes breastfeeding and recommends it to be exclusive until the baby is 6 months old. Breastfeeding has a positive impact on both the mother's and the infant's health and is directly associated with the decrease in diseases such as cancer, diabetes, cardiovascular disease, and inflammatory and infectious diseases. Currently, in Spain, only 39% of infants at 6 months are breastfed. The factors that influence the abandonment of breastfeeding are returning to work, the sensation of hypogalactia, problems to breastfeed, and breast complications, like mastitis, being the pain its main cause. Recent studies have associated pain while breastfeeding with mammary gland inflammation (mastitis) caused by dysbiosis.

In order to increase breastfeeding rates, it is necessary to find factors related to the progression of mastitis in breastfeeding women. In this context, the discovery of predictive biomarkers based on metabolic markers is key to act before or at the beginning of the progression of mastitis and thus reduce the rates of abandonment of breastfeeding due to pain.

The present project aims to identify and validate metabolic biomarkers capable of predicting mastitis. For this purpose, a prospective observational case-control hypothesis-free study will be carried out in order to identify and validate biomarkers of mastitis in breastfeeding women. The study will be performed in two phases: the discovery of the possible biomarkers and the validation of the biomarkers.

Breast milk will be collected at the beginning of the study and when women present symptoms compatible with mastitis. The presence or not of mastitis will be confirmed with a milk culture. Milk samples will be analyzed using non-targeted metabolomics approach. Using multivariate statistical models, the potential metabolites capable of discriminating the presence of mastitis in maternal milk will be identified. Later, these potential markers will be validated in independent samples.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Painful Breastfeeding and Bacterial or Yeast Infection

NCT01631461

Breast Infection

COMPLETED

Impact of Maternal COVID-19 Vaccines on Breast Milk

NCT04751734

COVID-19 Vaccines

COMPLETED

Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health

NCT04768244

Covid19

COMPLETED

Evaluation of the Effectiveness of LactApp

NCT05432700

Breast Feeding

COMPLETED NA

Study of the Breast Milk Microbiota and Its Influence on the Development of Early and Late Neonatal Bacterial Sepsis Under Three Months of Age.

NCT05490498

Neonatal Sepsis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Feeding Mastitis Mastitis Acute Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute mastitis (MA)

Lactating women with confirmed acute mastitis

No interventions assigned to this group

Subacute mastitis (SAM)

Lactating women with confirmed subacute mastitis

No interventions assigned to this group

Control (CT)

Lactating women with the absence of acute or subacute mastitis symptomatology.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Breastfeeding women with healthy full-term, singleton infants older than 1 months weeks and younger than 6 months.
* Provide written informed consent

Exclusion Criteria

* Immunocompromised suppressed women (i.e. HIV, following treatment with immunosuppressants or chemotherapy).
* Currently being treated for cancer
* Current infection being treated with antibiotics.
* Women who carry out a complete deferred breastfeeding.
* Women with babies presenting any syndrome, cleft lip or facial malformations.
* Currently tandem breastfeeding.
* Women who have had a premature delivery

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No